Logo image of ALGRO.PA

GROLLEAU SACA (ALGRO.PA) Stock Fundamental Analysis

EPA:ALGRO - Euronext Paris - Matif - FR0014005ZM5 - Common Stock - Currency: EUR

3.34  -0.02 (-0.6%)

Fundamental Rating

2

Taking everything into account, ALGRO scores 2 out of 10 in our fundamental rating. ALGRO was compared to 0 industry peers in the Unkown industry. ALGRO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALGRO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALGRO had negative earnings in the past year.
ALGRO had a negative operating cash flow in the past year.
ALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1M -1M 2M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA 0.02%
ROE 0.06%
ROIC 0.13%
ROA(3y)-0.08%
ROA(5y)N/A
ROE(3y)-0.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGRO.PA Yearly ROA, ROE, ROICALGRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

In the last couple of years the Profit Margin of ALGRO has declined.
In the last couple of years the Operating Margin of ALGRO has declined.
In the last couple of years the Gross Margin of ALGRO has remained more or less at the same level.
Industry RankSector Rank
OM 0.11%
PM (TTM) 0.02%
GM 51.15%
OM growth 3Y-74.31%
OM growth 5YN/A
PM growth 3Y-80.55%
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5YN/A
ALGRO.PA Yearly Profit, Operating, Gross MarginsALGRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGRO is destroying value.
Compared to 1 year ago, ALGRO has about the same amount of shares outstanding.
The debt/assets ratio for ALGRO is higher compared to a year ago.
ALGRO.PA Yearly Shares OutstandingALGRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M
ALGRO.PA Yearly Total Debt VS Total AssetsALGRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ALGRO has an Altman-Z score of 1.74. This is a bad value and indicates that ALGRO is not financially healthy and even has some risk of bankruptcy.
ALGRO has a Debt/Equity ratio of 0.58. This is a neutral value indicating ALGRO is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.02
WACC6.88%
ALGRO.PA Yearly LT Debt VS Equity VS FCFALGRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

ALGRO has a Current Ratio of 1.72. This is a normal value and indicates that ALGRO is financially healthy and should not expect problems in meeting its short term obligations.
ALGRO has a Quick Ratio of 1.24. This is a normal value and indicates that ALGRO is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.24
ALGRO.PA Yearly Current Assets VS Current LiabilitesALGRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

ALGRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.68%.
Measured over the past years, ALGRO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -80.45% on average per year.
The Revenue has grown by 8.91% in the past year. This is quite good.
The Revenue has been growing slightly by 0.34% on average over the past years.
EPS 1Y (TTM)-98.68%
EPS 3Y-80.45%
EPS 5YN/A
EPS Q2Q%-185.72%
Revenue 1Y (TTM)8.91%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%19.41%

3.2 Future

ALGRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 128.94% yearly.
The Revenue is expected to grow by 30.58% on average over the next years. This is a very strong growth
EPS Next Y-650%
EPS Next 2Y164.58%
EPS Next 3Y128.94%
EPS Next 5YN/A
Revenue Next Year20.88%
Revenue Next 2Y39.22%
Revenue Next 3Y30.58%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALGRO.PA Yearly Revenue VS EstimatesALGRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALGRO.PA Yearly EPS VS EstimatesALGRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 16.21 indicates a correct valuation of ALGRO.
The average S&P500 Price/Forward Earnings ratio is at 20.42. ALGRO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 16.21
ALGRO.PA Price Earnings VS Forward Price EarningsALGRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.73
ALGRO.PA Per share dataALGRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as ALGRO's earnings are expected to grow with 128.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y164.58%
EPS Next 3Y128.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALGRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROLLEAU SACA

EPA:ALGRO (5/8/2025, 7:00:00 PM)

3.34

-0.02 (-0.6%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.49M
Analysts86.67
Price Target7.65 (129.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.21
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.95
EV/EBITDA 10.73
EPS(TTM)0
EYN/A
EPS(NY)0.21
Fwd EY6.17%
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS11.99
BVpS4.57
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.06%
ROCE 0.17%
ROIC 0.13%
ROICexc 0.17%
ROICexgc 0.21%
OM 0.11%
PM (TTM) 0.02%
GM 51.15%
FCFM N/A
ROA(3y)-0.08%
ROA(5y)N/A
ROE(3y)-0.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-72.76%
ROICexcg growth 5YN/A
ROICexc growth 3Y-72.99%
ROICexc growth 5YN/A
OM growth 3Y-74.31%
OM growth 5YN/A
PM growth 3Y-80.55%
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5YN/A
F-Score2
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 6.9
Cap/Depr 54.26%
Cap/Sales 1.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.24
Altman-Z 1.74
F-Score2
WACC6.88%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)6.32%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.68%
EPS 3Y-80.45%
EPS 5YN/A
EPS Q2Q%-185.72%
EPS Next Y-650%
EPS Next 2Y164.58%
EPS Next 3Y128.94%
EPS Next 5YN/A
Revenue 1Y (TTM)8.91%
Revenue growth 3Y0.34%
Revenue growth 5YN/A
Sales Q2Q%19.41%
Revenue Next Year20.88%
Revenue Next 2Y39.22%
Revenue Next 3Y30.58%
Revenue Next 5YN/A
EBIT growth 1Y-94.59%
EBIT growth 3Y-74.22%
EBIT growth 5YN/A
EBIT Next Year2600%
EBIT Next 3Y405.93%
EBIT Next 5YN/A
FCF growth 1Y-1875.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.24%
OCF growth 3Y52.48%
OCF growth 5YN/A